Related Experiment Videos
[A randomized clinical study of preoperative chemotherapy for esophageal carcinoma]
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|January 11, 2002
Abstract
Objective:
To evaluate the effect of preoperative chemotherapy on the prognosis of stage II or III patients with esophageal carcinoma.
Methods:
From February 1991 to June 1994, 50 patients with stage II, III esophageal carcinoma were treated with preoperative combination (CDDP) chemotherapy and compared with 50 patients received operation alone.
Results:
The 5-year survival rate of the operation group and preoperative chemotherapy group was 32% and 46%, respectively. The difference was statistically significant.
Conclusion:
Preoperative chemotherapy improves survival of surgically treated esophageal cancer patients.